Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tvardi Therapeutics, Inc. (TVRD)
USD2.93
-0.17 (-5.48%)
US NASDAQ Healthcare Biotechnology
Address
3 Sugar Creek Center Boulevard 77478
Sugar Land, TX, US
Sugar Land, TX, US
CEO
Imran Alibhai
Website
tvarditherapeutics.com
IPO
2014-01-31
ISIN US1407553072
Also trades on
London Stock Exchange · 0HTC.L (USD)
NASDAQ Global Market · CARA (USD)
NASDAQ Global Market · TVRD (USD)
Description
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
News Sentiment (7d)
3 articles
- TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know Zacks Investment Research
- Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript Seeking Alpha
- Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.93
-0.17 (-5.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
159.6K
Beta
0.39
Float Shares
6.46M
Free Float %
68.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.51% | +8.45% | +37.24% | +6.99% | -6.13% | -7.44% | -84.69% | -18.78% | -18.78% | -18.78% | -18.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Hold
Price Targets & DCF
Current price
2.93
Low
3.00
+2.4%
Consensus
3.00
+2.4%
Median
3.00
+2.4%
High
3.00
+2.4%
DCF (Unlevered)
2.25
-23.4%
DCF (Levered)
2.64
-10.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 3 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
3.00
+2.4%
|
| Last Quarter | 1 |
3.00
+2.4%
|
| Last Year | 5 |
30.20
+930.7%
|
| All Time | 5 |
30.20
+930.7%
|
Quality scores
Altman Z-Score
-7.45
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-100.0% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+93.0% ★ Q1'26: -40.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +273.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+411.7% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 EPS Ana. |
Dec 2027 4 EPS Ana. |
Dec 2028 6 Rev. Ana. 3 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
341.3K
est.
|
1.05M
est.
|
10.59M
est.
|
20.74M
est.
|
135.08M
est: 28.07M (+381.2%)
|
23.03M
est: 23.35M (-1.4%)
|
41.87M
est: 53.45M (-21.7%)
|
20.97M
est: 27.41M (-23.5%)
|
7.14M
est: 7.15M (-0.1%)
|
—
est: 371.4K (-100.0%)
|
—
— – —
-100.0% YoY
|
—
— – —
|
1.17M
1.17M – 1.17M
|
11.64M
11.64M – 11.64M
+898.0% YoY
|
29.44M
29.44M – 29.44M
+152.8% YoY
|
| EBITDA |
-268.6K
est.
|
-824.2K
est.
|
-8.34M
est.
|
-16.32M
est.
|
8.73M
est: -22.09M (+139.5%)
|
-86.89M
est: -18.38M (-372.7%)
|
-83.80M
est: -42.07M (-99.2%)
|
-117.65M
est: -21.57M (-445.4%)
|
-62.60M
est: -4.29M (-1,360.0%)
|
-26.65M
est: -222.9K (-11,859.7%)
|
—
— – —
+100.0% YoY
|
—
— – —
|
-700.0K
-700.0K – -700.0K
|
-6.99M
-6.99M – -6.99M
-898.0% YoY
|
-17.66M
-17.66M – -17.66M
-152.8% YoY
|
| EBIT |
-269.1K
est.
|
-825.7K
est.
|
-8.35M
est.
|
-16.35M
est.
|
7.72M
est: -22.14M (+134.9%)
|
-88.44M
est: -18.42M (-380.3%)
|
-85.47M
est: -42.15M (-102.8%)
|
-117.91M
est: -21.61M (-445.6%)
|
-62.79M
est: -4.29M (-1,364.5%)
|
-26.75M
est: -222.9K (-11,902.3%)
|
—
— – —
+100.0% YoY
|
—
— – —
|
-700.0K
-700.0K – -700.0K
|
-6.99M
-6.99M – -6.99M
-898.0% YoY
|
-17.66M
-17.66M – -17.66M
-152.8% YoY
|
| Net Income |
-97.12M
est.
|
-100.61M
est.
|
-121.63M
est.
|
-139.74M
est.
|
8.41M
est: -66.59M (+112.6%)
|
-88.44M
est: -91.36M (+3.2%)
|
-85.47M
est: -74.12M (-15.3%)
|
-118.51M
est: -109.83M (-7.9%)
|
-70.87M
est: -352.11M (+79.9%)
|
-18.21M
est: -15.44M (-18.0%)
|
-24.97M
-26.72M – -14.44M
-61.7% YoY
|
-15.84M
-19.26M – -12.42M
+36.6% YoY
|
-18.81M
-35.10M – -2.53M
-18.8% YoY
|
-20.60M
-20.60M – -20.60M
-9.5% YoY
|
-14.60M
-14.60M – -14.60M
+29.1% YoY
|
| SGA |
485.0K
est.
|
1.49M
est.
|
15.05M
est.
|
29.47M
est.
|
20.94M
est: 39.89M (-47.5%)
|
27.98M
est: 33.19M (-15.7%)
|
30.13M
est: 75.97M (-60.3%)
|
27.65M
est: 38.95M (-29.0%)
|
26.39M
est: 11.36M (+132.2%)
|
8.74M
est: 590.6K (+1,379.3%)
|
—
— – —
-100.0% YoY
|
—
— – —
|
1.86M
1.86M – 1.86M
|
18.51M
18.51M – 18.51M
+898.0% YoY
|
46.81M
46.81M – 46.81M
+152.8% YoY
|
| EPS |
-63.86
est.
|
-66.15
est.
|
-79.97
est.
|
-91.88
est.
|
6.39
est: -43.79 (+114.6%)
|
-62.77
est: -60.07 (-4.5%)
|
-2.20
est: -48.74 (+95.5%)
|
-1.85
est: -72.22 (+97.4%)
|
-46.59
est: -45.24 (-3.0%)
|
-2.46
est: -2.23 (-10.3%)
|
-2.33
-3.43 – -1.86
-4.5% YoY
|
-2.08
-2.47 – -1.60
+10.7% YoY
|
-2.06
-4.51 – -0.33
+1.1% YoY
|
-2.65
-2.65 – -2.65
-28.5% YoY
|
-1.88
-1.88 – -1.88
+29.1% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | Barclays | Equal Weight | Underweight | Downgrade |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-23.61M
OE per share TTM
-4.92
Owner's Yield
-63.56%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
4.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
14
Total invested
4.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
14
-51 vs prev Q
New positions
7
Closed positions
58
Increased
9
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SLATE PATH CAPITAL LP | 704.1K +— (+0.0%) | 3.03M -24.4M (-89.0%) | 7.51% -1.029 pp | 0.04% -0.384 pp | USD23.33 -81.6% | 3 qtrs — |
| 2 | VANGUARD GROUP INC | 424.8K +5.7K (+1.3%) | 1.83M -14.5M (-88.8%) | 4.53% -0.553 pp | 0.00% 0.000 pp | USD23.84 -82.0% | 3 qtrs — |
| 3 | BLACKROCK, INC. | 391.0K +61.1K (+18.5%) | 1.68M -11.2M (-86.9%) | 4.17% +0.169 pp | 0.00% 0.000 pp | USD22.84 -81.2% | 3 qtrs — |
| 4 | AMERICAN FINANCIAL GROUP INC | 223.7K +223.7K (+100.0%) | 961.7K +961.7K (+100.0%) | 2.39% +2.385 pp | 0.35% +0.349 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 157.1K +9.2K (+6.2%) | 675.8K -5.1M (-88.3%) | 1.68% -0.118 pp | 0.00% 0.000 pp | USD25.78 -83.3% | 3 qtrs — |
| 6 | STATE STREET CORP | 115.5K +52.6K (+83.7%) | 496.7K -2.0M (-79.7%) | 1.23% +0.469 pp | 0.00% 0.000 pp | USD17.55 -75.5% | 3 qtrs — |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 104.5K +74.3K (+246.3%) | 449.4K -726.6K (-61.8%) | 1.11% +0.749 pp | 0.00% -0.001 pp | USD9.80 -56.1% | 3 qtrs — |
| 8 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 101.0K +78.7K (+351.7%) | 434.4K -437.2K (-50.2%) | 1.08% +0.806 pp | 0.00% -0.003 pp | USD11.97 -64.1% | 2 qtrs — |
| 9 | MORGAN STANLEY | 84.5K +80.7K (+2,131.0%) | 363.2K +215.7K (+146.2%) | 0.90% +0.855 pp | 0.00% +0.000 pp | USD5.15 -16.5% | 3 qtrs — |
| 10 | DUNCAN WILLIAMS ASSET MANAGEMENT, LLC | 80.8K +80.8K (+100.0%) | 311.8K +311.8K (+100.0%) | 0.86% +0.861 pp | 0.08% +0.078 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 11 | SQUAREPOINT OPS LLC | 51.8K +43.6K (+534.3%) | 222.7K -95.5K (-30.0%) | 0.55% +0.453 pp | 0.00% 0.000 pp | USD9.77 -56.0% | 2 qtrs — |
| 12 | NORTHERN TRUST CORP | 47.9K +5.5K (+13.0%) | 205.9K -1.4M (-87.5%) | 0.51% -0.003 pp | 0.00% 0.000 pp | USD25.06 -82.8% | 3 qtrs — |
| 13 | JANE STREET GROUP, LLC | 47.4K +47.4K (+100.0%) | 204.0K +204.0K (+100.0%) | 0.51% +0.506 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 14 | FARALLON CAPITAL MANAGEMENT LLC | 43.2K +— (+0.0%) | 185.9K -1.5M (-89.0%) | 0.46% -0.063 pp | 0.00% -0.006 pp | USD23.33 -81.6% | 3 qtrs — |
| 15 | UBS GROUP AG | 35.6K -12.9K (-26.7%) | 152.9K -1.7M (-91.9%) | 0.38% -0.209 pp | 0.00% 0.000 pp | USD29.50 -85.4% | 3 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 33.1K +9.1K (+37.9%) | 142.5K -793.9K (-84.8%) | 0.35% +0.062 pp | 0.00% 0.000 pp | USD29.45 -85.4% | 2 qtrs — |
| 17 | BANK OF AMERICA CORP /DE/ | 25.4K +10.0K (+65.2%) | 109.1K -489.5K (-81.8%) | 0.27% +0.084 pp | 0.00% +0.000 pp | USD15.82 -72.8% | 3 qtrs — |
| 18 | CITADEL ADVISORS LLC | 21.7K +21.7K (+100.0%) | 93.3K +93.3K (+100.0%) | 0.23% +0.231 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 19 | QUADRATURE CAPITAL LTD | 21.0K +21.0K (+100.0%) | 90.1K +90.1K (+100.0%) | 0.22% +0.224 pp | 0.00% +0.001 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 20 | BANK OF NEW YORK MELLON CORP | 18.1K +8.5K (+87.7%) | 78.0K -298.7K (-79.3%) | 0.19% +0.076 pp | 0.00% 0.000 pp | USD22.77 -81.1% | 2 qtrs — |
| 21 | RUSSELL INVESTMENTS GROUP, LTD. | 16.0K +14.9K (+1,351.5%) | 68.7K +25.8K (+60.2%) | 0.17% +0.157 pp | 0.00% +0.000 pp | USD6.69 -35.7% | 2 qtrs — |
| 22 | XTX TOPCO LTD | 12.8K +12.8K (+100.0%) | 55.2K +55.2K (+100.0%) | 0.14% +0.137 pp | 0.00% +0.001 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11.8K -3.5K (-22.7%) | 50.7K -544.5K (-91.5%) | 0.13% -0.059 pp | 0.00% 0.000 pp | USD26.63 -83.9% | 3 qtrs — |
| 24 | HRT FINANCIAL LP | 11.1K +11.1K (+100.0%) | 47.0K +47.0K (+100.0%) | 0.12% +0.118 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 25 | TWO SIGMA INVESTMENTS, LP | 10.5K +10.5K (+100.0%) | 45.1K +45.1K (+100.0%) | 0.11% +0.112 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 26 | SRS CAPITAL ADVISORS, INC. | 8.4K +6.2K (+277.2%) | 36.1K -50.7K (-58.4%) | 0.09% +0.063 pp | 0.00% 0.000 pp | USD11.88 -63.8% | 3 qtrs — |
| 27 | BARCLAYS PLC | 8.3K +1.6K (+24.6%) | 35.7K -224.2K (-86.3%) | 0.09% +0.008 pp | 0.00% 0.000 pp | USD21.23 -79.7% | 3 qtrs — |
| 28 | FMR LLC | 6.6K -75.6K (-92.0%) | 28.4K -3.2M (-99.1%) | 0.07% -0.927 pp | 0.00% 0.000 pp | USD38.97 -89.0% | 3 qtrs — |
| 29 | WELLS FARGO & COMPANY/MN | 6.0K +2.5K (+69.8%) | 25.9K -112.6K (-81.3%) | 0.06% +0.021 pp | 0.00% +0.000 pp | USD18.22 -76.4% | 3 qtrs — |
| 30 | RHUMBLINE ADVISERS | 3.1K -856.0 (-21.5%) | 13.4K -141.7K (-91.3%) | 0.03% -0.015 pp | 0.00% 0.000 pp | USD25.57 -83.2% | 3 qtrs — |
| 31 | DEUTSCHE BANK AG\ | 3.0K +— (+0.0%) | 13.0K -105.1K (-89.0%) | 0.03% -0.004 pp | 0.00% +0.000 pp | USD23.33 -81.6% | 3 qtrs — |
| 32 | NEW YORK STATE COMMON RETIREMENT FUND | 3.0K +— (+0.0%) | 13.0K -95.1K (-88.0%) | 0.03% -0.004 pp | 0.00% 0.000 pp | USD23.33 -81.6% | 3 qtrs — |
| 33 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.5K +2.2K (+614.8%) | 10.8K -2.9K (-21.1%) | 0.03% +0.023 pp | 0.00% 0.000 pp | USD8.51 -49.5% | 3 qtrs — |
| 34 | JPMORGAN CHASE & CO | 2.5K +562.0 (+29.3%) | 10.7K -64.0K (-85.7%) | 0.03% +0.003 pp | 0.00% +0.000 pp | USD20.59 -79.1% | 3 qtrs — |
| 35 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 2.3K +88.0 (+4.0%) | 9.8K -75.9K (-88.5%) | 0.02% -0.002 pp | 0.00% 0.000 pp | USD24.90 -82.7% | 3 qtrs — |
| 36 | SIMPLEX TRADING, LLC | 1.4K -1.6K (-52.5%) | 6.1K -109.9K (-94.7%) | 0.02% -0.021 pp | 0.00% 0.000 pp | USD38.97 -89.0% | 2 qtrs — |
| 37 | BNP PARIBAS ARBITRAGE, SNC | 1.3K +125.0 (+11.0%) | 5.4K -38.8K (-87.7%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD31.80 -86.5% | 3 qtrs — |
| 38 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 916.00 +— (+0.0%) | 3.9K -31.8K (-89.0%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD38.97 -89.0% | 2 qtrs — |
| 39 | LEGAL & GENERAL GROUP PLC | 421.00 +— (+0.0%) | 1.8K -14.6K (-89.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD27.45 -84.3% | 3 qtrs — |
| 40 | AMERITAS INVESTMENT PARTNERS, INC. | 349.00 +— (+0.0%) | 1.5K -12.1K (-89.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD23.33 -81.6% | 3 qtrs — |
| 41 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 331.00 +118.0 (+55.4%) | 1.4K -6.9K (-82.9%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD16.54 -74.0% | 3 qtrs — |
| 42 | PNC FINANCIAL SERVICES GROUP, INC. | 294.00 +246.0 (+512.5%) | 1.3K -607.0 (-32.4%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD9.96 -56.8% | 2 qtrs — |
| 43 | STERLING CAPITAL MANAGEMENT LLC | 292.00 +3.0 (+1.0%) | 1.3K -10.0K (-88.8%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD34.22 -87.4% | 3 qtrs — |
| 44 | ROYAL BANK OF CANADA | 294.00 -2.4K (-89.0%) | 1.0K -103.0K (-99.0%) | 0.00% -0.029 pp | 0.00% +0.000 pp | USD37.41 -88.5% | 3 qtrs — |
| 45 | AMALGAMATED BANK | 169.00 +52.0 (+44.4%) | 1.0K -4.0K (-80.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.47 -75.4% | 3 qtrs — |
| 46 | CWM, LLC | 206.00 +206.0 (+100.0%) | 1.0K +1.0K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 47 | ALLWORTH FINANCIAL LP | 141.00 +122.0 (+642.1%) | 607.00 -134.0 (-18.1%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD6.86 -37.3% | 3 qtrs — |
| 48 | JONES FINANCIAL COMPANIES LLLP | 125.00 +100.0 (+400.0%) | 538.00 -370.0 (-40.7%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD8.22 -47.7% | 3 qtrs — |
| 49 | CITIGROUP INC | 123.00 +51.0 (+70.8%) | 529.00 -2.3K (-81.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.43 -72.1% | 3 qtrs — |
| 50 | GROUP ONE TRADING, L.P. | 114.00 +100.0 (+714.3%) | 490.00 -56.0 (-10.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD6.63 -35.1% | 3 qtrs — |
| 51 | ADVISOR GROUP HOLDINGS, INC. | 29.00 +— (+0.0%) | 123.00 -896.0 (-87.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.31 -81.6% | 3 qtrs — |
| 52 | LRI INVESTMENTS, LLC | 27.00 +27.0 (+100.0%) | 116.00 +116.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.30 +0.0% | 1 qtrs NEW |
| 53 | MCILRATH & ECK, LLC | 20.00 +— (+0.0%) | 86.00 -693.0 (-89.0%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD23.30 -81.5% | 3 qtrs — |
| 54 | HARBOUR INVESTMENTS, INC. | 15.00 +— (+0.0%) | 65.00 -520.0 (-88.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD24.27 -82.3% | 3 qtrs — |
| 55 | — | 12.00 +— (+0.0%) | 52.00 -416.0 (-88.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.25 -81.5% | 3 qtrs — |
| 56 | MAI CAPITAL MANAGEMENT | 10.00 +— (+0.0%) | 43.00 -347.0 (-89.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.30 -81.5% | 3 qtrs — |
| 57 | IFP ADVISORS, INC | 6.00 +6.0 (+100.0%) | 26.00 +26.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.17 +3.1% | 1 qtrs NEW |
| 58 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 6.00 +6.0 (+100.0%) | 26.00 +26.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.17 +3.1% | 1 qtrs NEW |
| 59 | EVERSOURCE WEALTH ADVISORS, LLC | 5.00 +5.0 (+100.0%) | 22.00 +22.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.20 +2.4% | 1 qtrs NEW |
| 60 | TRUVESTMENTS CAPITAL LLC | 4.00 +— (+0.0%) | 17.00 -139.0 (-89.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.25 -81.5% | 3 qtrs — |
| 61 | SBI SECURITIES CO., LTD. | 4.00 +— (+0.0%) | 17.00 -139.0 (-89.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.25 -81.5% | 3 qtrs — |
| 62 | LARSON FINANCIAL GROUP LLC | 2.00 +2.0 (+100.0%) | 9.00 +9.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.00 +7.5% | 1 qtrs NEW |
| 63 | FRONT ROW ADVISORS LLC | 1.00 +1.0 (+100.0%) | 4.00 +4.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.00 +7.5% | 1 qtrs NEW |
| 64 | CORNERSTONE PLANNING GROUP LLC | 1.00 +1.0 (+100.0%) | 4.00 +4.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.00 +7.5% | 1 qtrs NEW |
| 65 | COMERICA BANK | 1.00 +— (+0.0%) | 4.00 -35.0 (-89.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD23.00 -81.3% | 3 qtrs — |
| 66 | SCHONFELD STRATEGIC ADVISORS LLC | — -19.1K (-100.0%) | — -745.6K (-100.0%) | 0.00% -0.232 pp | 0.00% -0.004 pp | USD— | 2 qtrs SOLD |
| 67 | MONACO ASSET MANAGEMENT SAM | — -13.6K (-100.0%) | — -529.6K (-100.0%) | 0.00% -0.165 pp | 0.00% -0.032 pp | USD— | 2 qtrs SOLD |
| 68 | NEWEDGE ADVISORS, LLC | — -8.0 (-100.0%) | — -312.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 69 | NUVEEN, LLC | — -6.0K (-100.0%) | — -231.9K (-100.0%) | 0.00% -0.072 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 70 | PARKMAN HEALTHCARE PARTNERS LLC | — -65.0K (-100.0%) | — -2.5M (-100.0%) | 0.00% -0.788 pp | 0.00% -0.264 pp | USD— | 2 qtrs SOLD |
| 71 | PERSISTENT ASSET PARTNERS LTD | — -500.0 (-100.0%) | — -19.5K (-100.0%) | 0.00% -0.006 pp | 0.00% -0.013 pp | USD— | 2 qtrs SOLD |
| 72 | INVESCO LTD. | — -82.6K (-100.0%) | — -3.2M (-100.0%) | 0.00% -1.002 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 73 | IKARIAN CAPITAL, LLC | — -19.0K (-100.0%) | — -740.4K (-100.0%) | 0.00% -0.230 pp | 0.00% -0.075 pp | USD— | 2 qtrs SOLD |
| 74 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | — -4.0 (-100.0%) | — -156.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 75 | 683 CAPITAL MANAGEMENT, LLC | — -176.0K (-100.0%) | — -6.8M (-100.0%) | 0.00% -2.135 pp | 0.00% -0.354 pp | USD— | 3 qtrs SOLD |
| 76 | METLIFE INVESTMENT MANAGEMENT, LLC | — -2.8K (-100.0%) | — -109.9K (-100.0%) | 0.00% -0.034 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 77 | DIADEMA PARTNERS LP | — -2.2K (-100.0%) | — -85.1K (-100.0%) | 0.00% -0.027 pp | 0.00% -0.022 pp | USD— | 2 qtrs SOLD |
| 78 | STATE OF WYOMING | — -1.3K (-100.0%) | — -46.1K (-100.0%) | 0.00% -0.016 pp | 0.00% -0.005 pp | USD— | 2 qtrs SOLD |
| 79 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | — -1.0K (-100.0%) | — -39.0K (-100.0%) | 0.00% -0.012 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 80 | CAPTION MANAGEMENT, LLC | — -1.7K (-100.0%) | — -66.2K (-100.0%) | 0.00% -0.021 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 81 | BOOTHBAY FUND MANAGEMENT, LLC | — -20.2K (-100.0%) | — -786.8K (-100.0%) | 0.00% -0.245 pp | 0.00% -0.011 pp | USD— | 2 qtrs SOLD |
| 82 | VESTAL POINT CAPITAL, LP | — -167.0K (-100.0%) | — -6.5M (-100.0%) | 0.00% -2.025 pp | 0.00% -0.294 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 23 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Russell 2000 Value ETF VTWV | 0.00% | 13.0K | 0.06% |
| 2 | Vanguard Russell 2000 ETF VTWO | 0.00% | 100.8K | 0.06% |
| 3 | Vanguard Extended Market ETF VXF | 0.00% | 284.0K | 0.05% |
| 4 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 1.6K | 0.06% |
| 5 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.9K | 0.03% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 391.40 | 0.17% |
| 7 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 5.3K | 0.17% |
| 8 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 375.47 | 0.17% |
| 9 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 5.1K | 0.17% |
| 10 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.9K | 0.03% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
86.5K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+86,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | O'Brien Stephen Paul | Officer | A-Award | A | Employee Stock Option (right to buy) | 15,000 | 3.90 | 58.5K | 15,000 | D | ↗ |
| 2026-01-29 | Kauh John Saewook M.D. | Officer | A-Award | A | Employee Stock Option (right to buy) | 45,000 | 3.90 | 175.5K | 45,000 | D | ↗ |
| 2026-01-29 | Conn Avi Daniel | Officer | A-Award | A | Employee Stock Option (right to buy) | 45,000 | 3.90 | 175.5K | 45,000 | D | ↗ |
| 2026-01-29 | Alibhai Imran Nizamudin | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 115,000 | 3.90 | 448.5K | 115,000 | D | ↗ |
| 2025-12-16 | O'Brien Stephen Paul | Officer | A-Award | A | Employee Stock Option (right to buy) | 4,000 | 4.20 | 16.8K | 4,000 | D | ↗ |
| 2025-12-16 | Kauh John Saewook M.D. | Officer | A-Award | A | Employee Stock Option (right to buy) | 17,500 | 4.20 | 73.5K | 17,500 | D | ↗ |
| 2025-12-16 | Conn Avi Daniel | Officer | A-Award | A | Employee Stock Option (right to buy) | 17,500 | 4.20 | 73.5K | 17,500 | D | ↗ |
| 2025-12-16 | Alibhai Imran Nizamudin | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 47,500 | 4.20 | 199.5K | 47,500 | D | ↗ |
| 2025-07-07 | Tweardy Samuel David | 10% Owner | J-Other | D | Common Stock | 315,658 | 0.00 | — | 0 | I | ↗ |
| 2025-04-17 | Wirk Shaheen | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | WYZGA MICHAEL S | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | Smith Cynthia | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | Shiff Susan Ph.D. | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | Shah Sujal | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | O'Brien Stephen Paul | Officer | A-Award | A | Employee Stock Option (right to buy) | 7,213 | 17.04 | 122.9K | 7,213 | D | ↗ |
| 2025-04-17 | Larson Jeffrey Leroy | Officer | A-Award | A | Employee Stock Option (right to buy) | 10,820 | 17.04 | 184.4K | 10,820 | D | ↗ |
| 2025-04-17 | Kauh John Saewook M.D. | Officer | A-Award | A | Employee Stock Option (right to buy) | 36,210 | 17.04 | 617.0K | 36,210 | D | ↗ |
| 2025-04-17 | HALL WALLACE L JR | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 17.04 | 204.5K | 12,000 | D | ↗ |
| 2025-04-17 | Conn Avi Daniel | Officer | A-Award | A | Employee Stock Option (right to buy) | 43,547 | 17.04 | 742.0K | 43,547 | D | ↗ |
| 2025-04-17 | Chen Yixin | Officer | A-Award | A | Employee Stock Option (right to buy) | 7,213 | 17.04 | 122.9K | 7,213 | D | ↗ |
| 2025-04-17 | Alibhai Imran Nizamudin | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 182,320 | 17.04 | 3.11M | 182,320 | D | ↗ |
| 2025-04-15 | Wirk Shaheen | Director | A-Award | A | Common Stock | 176,030 | 0.00 | — | 176,030 | I | ↗ |
| 2025-04-15 | WYZGA MICHAEL S | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | Tweardy Samuel David | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 315,658 | I | ↗ |
| 2025-04-15 | Smith Cynthia | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | Shah Sujal | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | O'Brien Stephen Paul | Officer | A-Award | A | Employee Stock Option (right to buy) | 11,399 | 4.70 | 53.6K | 11,399 | D | ↗ |
| 2025-04-15 | Larson Jeffrey Leroy | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | Kauh John Saewook M.D. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | HALL WALLACE L JR | Director | A-Award | A | Common Stock | 44,712 | 0.00 | — | 44,712 | I | ↗ |
| 2025-04-15 | Conn Avi Daniel | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | Chen Yixin | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-15 | Alibhai Imran Nizamudin | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 207,881 | 0.68 | 141.4K | 207,881 | D | ↗ |
Executive team
Top executives
Shares Outstanding
9.38M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Imran Alibhai | Chief Executive Officer & Director | 942.2K | — |
| John Kauh | Chief Medical Officer | 702.3K | — |
| Dan Conn | CFO & Corporate Secretary | 603.0K | male |
| Michael T. Lewis | Co-Founder & Scientific Advisory Board Member | — | — |
| Ronald A. DePinho | Co-Founder & Chairman of Scientific Advisory Board | — | — |
| Stephen O'Brien | Vice President of Finance & Corporate Controller | — | male |
| Wallace Hall | Founder, President & Director | — | male |
| Yixin Chen | Vice President of CMC | — | — |
| David J. Tweardy | Co-Founder & Scientific Advisory Board Member | — | male |
| Jeffrey Larson DABT | Senior Vice President of R&D | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TVRD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
